bb2121
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for bb2121, covering 2022-12-15 to 2026-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) [Phase 3]